Also trades as: PREV.CN (CNQ) · $vol 0M
PRVCF OTC
PreveCeutical Medical Inc.
1W: -42.8%
1M: -41.1%
3M: -22.3%
YTD: -41.8%
1Y: -56.2%
3Y: -46.4%
5Y: -48.5%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$812K
+15.6% ▲
Net Income
-$1M
+7.8% ▲
EPS (Diluted)
$-0.00
+8.3% ▲
EBITDA
-$753K
+16.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $75K | $5K | $10K | $10K | $0 |
| Gross Profit | -$75K | -$5K | -$10K | -$10K | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $315K | $172K | $78K | $92K | $82 |
| SG&A Expenses | $2M | $768K | $1M | $813K | $660K |
| Operating Expenses | $2M | $898K | $1M | $963K | $812 |
| Operating Income | -$2M | -$898K | -$1M | -$963K | -$812K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $640K | $467K | $237K | $310K | $327 |
| Income Before Tax | -$4M | -$2M | -$1M | -$1M | -$1K |
| Tax Expense | -$6K | -$20K | $0 | $0 | $0 |
| Net Income | -$4M | -$2M | -$1M | -$1M | -$1M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$2M | -$830K | -$1M | -$905K | -$753K |
| Shares Outstanding | 456M | 508M | 522M | 535M | 536M |